M B Sugars And Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Nashik, Maharashtra, India, established in 1996.
1996 Nashik, Maharashtra, India Active
Last Updated:
Access Report
About M B Sugars And Pharmaceuticals Private Limited

M B Sugars And Pharmaceuticals Private Limited, a active private limited company, was established on 02 February 1996 in Nashik, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U15420MH1996PTC096832. Registered under ROC Roc Mumbai Ii. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹7.32 M.

Formerly known as M B Sugars And Pharmaceuticals Limited. It upholds a compliant status. Employing 201 professional, Its leadership includes Rushabh Anilkumar Lodha (Director), Dineshkumar Bhagchand Lodha (Director), Vijaykumar Bhagchand Lodha (Managing Director). Past directors included Bhagchand Motilal Lodha. It holds ₹67.35 Cr open charges and ₹32.28 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Lodha Bhavanp B No 31 Malegaon, Nashik, Maharashtra, 423203.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U15420MH1996PTC096832

  • Registration Number

    096832

  • Incorporation Date

    02 February 1996

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹7.32 M

  • ROC Code

    Roc Mumbai Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 7.32 M
  • Company Age 30 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 67.35 Cr
  • Satisfied Charges ₹ 32.28 Cr
  • Revenue Growth **** 19.30%
  • Profit Growth **** 662.61%
  • Ebitda **** -5.44%
  • Net Worth 185.11%
  • Total Assets **** 71.26%
Company report

M B Sugars And Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into M B Sugars And Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at M B Sugars And Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rushabh Anilkumar Lodha Director 01 Apr 2008 Current
Dineshkumar Bhagchand Lodha Director 02 Feb 1996 Current
Vijaykumar Bhagchand Lodha Managing Director 02 Feb 1996 Current
Saurabh Dineshkumar Lodha Director 14 Mar 2019 Current
Samyak Vijaykumar Lodha Director 06 Jun 2007 Current
Anilkumar Bhagchand Lodha Director 02 Feb 1996 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Oct 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of M B Sugars And Pharmaceuticals.

M B Sugars And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.3% increase. The company also saw a substantial improvement in profitability, with a 662.61% increase in profit. The company's net worth Soared by an impressive increase of 185.11%.

M B Sugars And Pharmaceuticals revenue growth over time
M B Sugars And Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 19.30%
*******
*******
*******
*******
Revenue from Operations
*******
 17.13%
*******
*******
*******
*******
Total Assets
*******
 71.26%
*******
*******
*******
*******
Profit or Loss
*******
 662.61%
*******
*******
*******
*******
Net Worth
*******
 185.11%
*******
*******
*******
*******
EBITDA
*******
 -5.44%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of M B Sugars And Pharmaceuticals?

In 2023, M B Sugars And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹673,505,500.00

Satisfied Charges

₹322,805,000.00

Charges Breakdown by Lending Institutions
  • Others : 66.45 Cr
  • Dbs Bank Ltd : 0.90 Cr
Latest Charge Details
Date Lender Amount Status
28 Aug 2025 Others ₹15.00 Cr Open
09 Apr 2024 Others ₹1.35 Cr Open
09 Apr 2024 Others ₹1.35 Cr Open
29 Mar 2024 Others ₹1.35 Cr Open
07 Nov 2023 Others ₹20.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at M B Sugars And Pharmaceuticals?

M B Sugars And Pharmaceuticals has a workforce of 201 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of M B Sugars And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M B Sugars And Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on M B Sugars And Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    M B Sugars And Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101146026 was registered on 28 Aug 2025. was completed.

  • Charges

    Progress on A charge registered on 19 Oct 2022 via Charge ID 100621386 with Others was fully satisfied on 04 Apr 2025. was documented.

  • Charges

    A charge registered on 25 Jun 2015 via Charge ID 10591086 with Dbs Bank Ltd was fully satisfied on 04 Apr 2025. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 25 Jun 2015 via Charge ID 10591084 with Dbs Bank Ltd was fully satisfied on 04 Apr 2025. was documented.

  • Charges

    The activity A charge registered on 08 Jan 2020 via Charge ID 100313420 with Others was fully satisfied on 03 Apr 2025. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of M B Sugars And Pharmaceuticals Private Limited?

The CIN of M B Sugars And Pharmaceuticals Private Limited is U15420MH1996PTC096832.

Where is M B Sugars And Pharmaceuticals Private Limited headquartered?

M B Sugars And Pharmaceuticals Private Limited is headquartered at Lodha Bhavanp B No 31 Malegaon, Nashik, Maharashtra, 423203.

When was M B Sugars And Pharmaceuticals Private Limited incorporated?

M B Sugars And Pharmaceuticals Private Limited was incorporated on 02 February 1996.

Who are the current directors of M B Sugars And Pharmaceuticals Private Limited?

The current directors of M B Sugars And Pharmaceuticals Private Limited are

What is the primary industry of M B Sugars And Pharmaceuticals Private Limited?

The primary industry of M B Sugars And Pharmaceuticals Private Limited is Manufacturing.

Is M B Sugars And Pharmaceuticals Private Limited a listed company?

M B Sugars And Pharmaceuticals Private Limited is unlisted.

What is the capital structure of M B Sugars And Pharmaceuticals Private Limited?

The authorized capital of M B Sugars And Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹7.32 M.

What is the compliance status of M B Sugars And Pharmaceuticals Private Limited?

The compliance status of M B Sugars And Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available